1. Home
  2. ACCO vs OCGN Comparison

ACCO vs OCGN Comparison

Compare ACCO & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$4.22

Market Cap

353.3M

ML Signal

HOLD

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.24

Market Cap

419.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCO
OCGN
Founded
1893
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.3M
419.8M
IPO Year
2005
2014

Fundamental Metrics

Financial Performance
Metric
ACCO
OCGN
Price
$4.22
$1.24
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.00
$9.75
AVG Volume (30 Days)
608.8K
4.8M
Earning Date
04-30-2026
05-05-2026
Dividend Yield
9.26%
N/A
EPS Growth
141.51
31.58
EPS
0.20
N/A
Revenue
$1,524,700,000.00
N/A
Revenue This Year
$3.10
N/A
Revenue Next Year
$0.89
$1,718.38
P/E Ratio
$21.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.81
$0.93
52 Week High
$4.39
$2.73

Technical Indicators

Market Signals
Indicator
ACCO
OCGN
Relative Strength Index (RSI) 57.81 41.34
Support Level $3.73 $1.13
Resistance Level $4.36 $1.58
Average True Range (ATR) 0.14 0.07
MACD 0.02 -0.01
Stochastic Oscillator 73.00 25.81

Price Performance

Historical Comparison
ACCO
OCGN

About ACCO Acco Brands Corporation

ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Share on Social Networks: